Advances in Cancer Research

Provides invaluable information on the fast-moving field of cancer research that includes outstanding, original reviews on a variety of topics

Kenneth D. Tew (Volume editor), Paul B. Fisher (Volume editor)

9780128151273

Hardback, published 17 March 2018

248 pages
22.9 x 15.1 x 2.1 cm, 0.54 kg

Advances in Cancer Research, Volume 138, the latest release in this ongoing, well-regarded serial provides invaluable information on the exciting and fast-moving field of cancer research. This volume presents original reviews on research bridging oncology and gene expression, with this volume covering unconventional approaches to modulating the immunogenicity of tumor cells, tumor dormancy and immunoediting, the emerging role of anti-apoptotic Bcl-2 family proteins in chemoresistance, Beclin-1 and autophagy, MDA-7/IL-24, and nanotechnology and medicine.

1. Leveraging Epigenetics to Enhance the Cellular Response to Chemotherapies and Improve Tumor ImmunogenicityLiliya Tyutyunyk-Massey, Syed Haqqani, Reshma Mandava, Kirubel Kentiba, Mallika Dammalapati, Nga Dao, Joshua Haueis, David Gewirtz and Joseph W. Landry2. VDAC Regulation: A Mitochondrial Target to Stop Cell ProliferationDiana Fang and Eduardo N. Maldonado3. Acquired Resistance to Drugs Targeting Tyrosine KinasesSteven A. Rosenzweig4. Extracellular Regulated Kinases: Signaling From Ras to ERK Substrates to Control Biological OutcomesScott T. Eblen5. Role of MDA-7/IL-24 a Multifunction Protein in Human DiseasesMitchell E. Menezes, Praveen Bhoopathi, Anjan K. Pradhan, Luni Emdad, Swadesh K. Das, Chunqing Guo, Xiang-Yang Wang, Devanand Sarkar and Paul B. Fisher6. Advances and Challenges of HDAC Inhibitors in Cancer TherapeuticsJesse J. McClure, Xiaoyang Li and C. James Chou7. Prospects of Gene Therapy to Treat MelanomaMitchell E. Menezes, Sarmistha Talukdar, Stephen L. Wechman, Swadesh K. Das, Luni Emdad, Devanand Sarkar and Paul B. Fisher

Subject Areas: Oncology [MJCL]